FDA Drug Shortage Database
Ketorolac (Toradol) shortage
The FDA Drug Shortage Database lists 13 of 26 ketorolac presentations as limited or unavailable (updated October 6, 2026); the first entry was posted on March 23, 2018. 12 more presentations are on the list as available.
- Generic listed
- In shortage
- Boxed warning
Check it at the source: the FDA Drug Shortage Database.
Which strengths are short?
| Strength | Limited or unavailable now | Listed now, available | Resolved or discontinued |
|---|---|---|---|
| 10mg tablet | 0 | 0 | 1 |
| 15mg/1ml injection | 5 | 3 | 0 |
| 30mg/1ml injection | 6 | 8 | 0 |
| 60mg/2ml injection | 2 | 1 | 0 |
Which presentations are listed?
Limited or unavailable now (13)
| Presentation | Company | Status and dates | Availability and reason given |
|---|---|---|---|
| Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0338-0069-10) | Baxter Healthcare | Current posted June 6, 2018, updated October 2, 2026 | Unavailable; Demand increase for the drug |
| Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0409-3793-01) | Hospira, Inc., a Pfizer Company | Current posted March 26, 2018, updated September 22, 2026 | Unavailable; Other |
| Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0641-6041-25) | Hikma Pharmaceuticals USA, Inc. | Current posted June 6, 2018, updated September 18, 2026 | Unavailable; Other |
| Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 25021-700-01) | Sagent Pharmaceuticals | Current posted March 26, 2018, updated September 18, 2026 | Unavailable; Delay in shipping of the drug |
| Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 76045-107-10) | Fresenius Kabi USA, LLC | Current posted March 23, 2018, updated October 6, 2026 | Unavailable; Other |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0409-3795-01) | Hospira, Inc., a Pfizer Company | Current posted March 26, 2018, updated September 22, 2026 | Unavailable; Other |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0641-6042-25) | Hikma Pharmaceuticals USA, Inc. | Current posted June 6, 2018, updated September 18, 2026 | Unavailable; Other |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0641-6043-25) | Hikma Pharmaceuticals USA, Inc. | Current posted June 6, 2018, updated September 18, 2026 | Unavailable; Other |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 63323-162-01) | Fresenius Kabi USA, LLC | Current posted March 23, 2018, updated September 15, 2026 | Unavailable; Delay in shipping of the drug |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 63323-162-02) | Fresenius Kabi USA, LLC | Current posted March 23, 2018, updated September 15, 2026 | Unavailable; Delay in shipping of the drug |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 76045-104-10) | Fresenius Kabi USA, LLC | Current posted March 23, 2018, updated October 6, 2026 | Unavailable; Other |
| Ketorolac Tromethamine, Injection, 60 mg/2 mL (30 mg/mL) (NDC 0409-3796-01) | Hospira, Inc., a Pfizer Company | Current posted March 26, 2018, updated September 22, 2026 | Unavailable; Other |
| Ketorolac Tromethamine, Injection, 60 mg/2 mL (NDC 76045-105-20) | Fresenius Kabi USA, LLC | Current posted March 23, 2018, updated October 6, 2026 | Unavailable; Other |
Listed now, available (12)
| Presentation | Company | Status and dates | Availability and reason given |
|---|---|---|---|
| Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 25021-700-01) | Gland Pharma Limited | Current posted March 23, 2018, updated July 22, 2026 | Available |
| Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 62332-599-25) | Alembic Pharmaceuticals | Current posted March 23, 2018, updated May 15, 2026 | Available |
| Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 63323-161-01) | Fresenius Kabi USA, LLC | Current posted March 23, 2018, updated October 6, 2026 | Available |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0338-0072-25) | Baxter Healthcare | Current posted June 6, 2018, updated October 2, 2026 | Available |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-01) | Sagent Pharmaceuticals | Current posted March 26, 2018, updated September 18, 2026 | Available |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-01) | Gland Pharma Limited | Current posted March 23, 2018, updated July 22, 2026 | Available; Demand increase for the drug |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-02) | Gland Pharma Limited | Current posted March 23, 2018, updated July 22, 2026 | Available; Demand increase for the drug |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-02) | Sagent Pharmaceuticals | Current posted March 26, 2018, updated September 18, 2026 | Available |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 62332-600-25) | Alembic Pharmaceuticals | Current posted March 23, 2018, updated May 15, 2026 | Available |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 72266-118-25) | Gland Pharma Limited | Current posted June 6, 2018, updated July 22, 2026 | Available; Demand increase for the drug |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 72266-119-25) | Gland Pharma Limited | Current posted June 6, 2018, updated July 22, 2026 | Available; Demand increase for the drug |
| Ketorolac Tromethamine, Injection, 60 mg/2 mL (NDC 62332-601-25) | Alembic Pharmaceuticals | Current posted March 23, 2018, updated May 15, 2026 | Available |
Resolved or discontinued (1)
| Presentation | Company | Status and dates | Availability and reason given |
|---|---|---|---|
| Ketorolac Tromethamine, Tablet, 10 mg (NDC 0378-1134-01) | Mylan Pharmaceuticals Inc., a Viatris Company | To Be Discontinued posted April 20, 2026, updated April 20, 2026 | not given |
Source: FDA Drug Shortage Database via openFDA, read October 8, 2026
What next?
- Every shortage now
- medicines by presentations in shortage